Ranbaxy Reported Discussing Use Of Ind Swift For Lipitor Generic API
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories is turning to fellow Indian drug maker Ind Swift to help it launch a generic of the world's biggest-selling drug, Lipitor, in the United States Nov. 30